Expression and significance of MicroRNA-183 in hepatocellular carcinoma

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Liang, Zenghui ^a   Gao, Yingtang ^b   Shi, Wenxia ^b   Zhai, Daokuan ^b   Li, Shilei ^a   Jing, Li ^b   Guo, Hua ^b   Liu, Tong ^b   Wang, Yajie ^a   Du, Zhi ^a,b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN THIRD CENTRAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 183; UNCLASSIFIED DRUG; MIRN183 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UPREGULATION; CASE CONTROL STUDY; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; PROGNOSIS;

CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; HEPATITIS B; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84886653294     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/381874     Document Type: Article

References (24)

1. Perz J. F., Armstrong G. L., Farrington L. A., Hutin Y. J. F., Bell B. P., The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. Journal of Hepatology 2006 45 4 529 538 2-s2.0-33748114343 10.1016/j.jhep.2006.05.013 (Pubitemid 44307383)
2. Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D., Global cancer statistics. CA Cancer Journal for Clinicians 2011 61 2 69 90 2-s2.0-79952232216 10.3322/caac.20107
3. Giordano S., Columbano A., MicroRNAs: new tools for diagnosis, prognosis and therapy in HCC? Hepatology 2013 57 2 840 847 10.1002/hep.26095
4. Zhu W., Liu X., He J., Chen D., Hunag Y., Zhang Y. K., Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study. BMC Cancer 2011 11 article 393 2-s2.0-80053258276 10.1186/1471-2407-11-393
5. Tanaka H., Sasayama T., Tanaka K., Nakamizo S., Nishihara M., Mizukawa K., Kohta M., Koyama J., Miyake S., Taniguchi M., Hosoda K., Kohmura E., MicroRNA-183 upregulates HIF-1alpha by targeting isocitrate dehydrogenase 2 (IDH2) in glioma cells. Journal of Neuro-Oncology 2013 111 273 283 10.1007/s11060-012-1027-9
6. Lowery A. J., Miller N., Dwyer R. M., Kerin M. J., Dysregulated miR-183 inhibits migration in breast cancer cells. BMC Cancer 2010 10 article 502 2-s2.0-77956677773 10.1186/1471-2407-10-502
7. Zhu J., Feng Y., Ke Z., Yang Z., Zhou J., Huang X., Wang L., Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin. The American Journal of Pathology 2012 180 2440 2451 10.1016/j.ajpath.2012.02.023
8. Wang G., Mao W., Zheng S., MicroRNA-183 regulates Ezrin expression in lung cancer cells. FEBS Letters 2008 582 25-26 3663 3668 2-s2.0-53949115677 10.1016/j.febslet.2008.09.051
9. Li J., Fu H., Xu C., Tie Y., Xing R., Zhu J., Qin Y., Sun Z., Zheng X., MiR-183 inhibits TGF- β 1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells. BMC Cancer 2010 10 article 354 2-s2.0-77955107314 10.1186/1471-2407-10-354
10. Liu A. M., Yao T. J., Wang W., Wong K. F., Lee N. P., Fan S. T., Poon R. T. P., Gao C., Luk J. M., Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study. BMJ Open 2012 2 2 e000825 2-s2.0-84860141964 10.1136/bmjopen-2012-000825
11. Goeppert B., Schmezer P., Dutruel C., Oakes C., Renner M., Breinig M., Warth A., Vogel M. N., Mittelbronn M., Mehrabi A., Gdynia G., Penzel R., Longerich T., Breuhahn K., Popanda O., Plass C., Schirmacher P., Kern M. A., Down-regulation of tumor suppressor a kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms. Hepatology 2010 52 6 2023 2033 2-s2.0-78649613036 10.1002/hep.23939
12. Li J. B., Shi W. X., Gao Y. T., Yang B., Jing X., Shan S. G., Wang Y., Du Z., Analysis of microRNA expression profiles in human hepatitis B virus-related hepatocellular carcinoma. Clinical Laboratory 2013 10.7754/Clin.Lab.2012.120901
13. Zhang J., Yang Y., Yang T., Liu Y., Li A., Fu S., Wu M., Pan Z., Zhou W., MicroRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. British Journal of Cancer 2010 103 8 1215 1220 2-s2.0-77957982588 10.1038/sj.bjc.6605895
14. Zheng Y., Yin L., Chen H., Yang S., Pan C., Lu S., Miao M., Jiao B., miR-376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma. FEBS Letters 2012 586 16 2396 2403 10.1016/j.febslet.2012.05.054
15. Xu D., He X., Chang Y., Xu C., Jiang X., Sun S., Lin J., Inhibition of miR-96 expression reduces cell proliferation and clonogenicity of HepG2 hepatoma cells. Oncology Reports 2013 29 2 653 661 10.3892/or.2012.2138
16. Bandrés E., Cubedo E., Agirre X., Malumbres R., Zárate R., Ramirez N., Abajo A., Navarro A., Moreno I., Monzó M., García-Foncillas J., Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Molecular Cancer 2006 5 article 29 2-s2.0-33747628074 10.1186/1476-4598-5-29 (Pubitemid 44264064)
17. Wang J., Li J., Shen J., Wang C., Yang L., Zhang X., MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma. BMC Cancer 2012 12 article 227
18. Ura S., Honda M., Yamashita T., Ueda T., Takatori H., Nishino R., Sunakozaka H., Sakai Y., Horimoto K., Kaneko S., Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 2009 49 4 1098 1112 2-s2.0-65449154685 10.1002/hep.22749
19. Jiang J., Gusev Y., Aderca I., Mettler T. A., Nagorney D. M., Brackett D. J., Roberts L. R., Schmittgen T. D., Association of microRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clinical Cancer Research 2008 14 2 419 427 2-s2.0-38949184246 10.1158/1078-0432.CCR-07-0523 (Pubitemid 351226109)
20. Murakami Y., Yasuda T., Saigo K., Urashima T., Toyoda H., Okanoue T., Shimotohno K., Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006 25 17 2537 2545 2-s2.0-33646157967 10.1038/sj.onc.1209283
21. Zhu X. M., Wu L. J., Xu J., Yang R., Wu F. S., Let-7c MicroRNA expression and clinical significance in hepatocellular carcinoma. Journal of International Medical Research 2011 39 6 2323 2329 2-s2.0-84555170184
22. Li J., Wang Y., Yu W., Chen J., Luo J., Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance. Biochemical and Biophysical Research Communications 2011 406 1 70 73 2-s2.0-79952193037 10.1016/j.bbrc.2011.01.111
23. Croce C. M., Oncogenes and cancer. New England Journal of Medicine 2008 358 5 502 511 2-s2.0-38749114995 10.1056/NEJMra072367 (Pubitemid 351185806)
24. Budhu A., Jia H. L., Forgues M., Liu C. G., Goldstein D., Lam A., Zanetti K. A., Ye Q. H., Qin L. X., Croce C. M., Tang Z. Y., Xin W. W., Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 2008 47 3 897 907 2-s2.0-40949087185 10.1002/hep.22160 (Pubitemid 351449681)